Search Results - "Ikeda, Daishiro"

Refine Results
  1. 1

    A New Terrein Glucoside, a Novel Inhibitor of Angiogenin Secretion in Tumor Angiogenesis by Arakawa, Masayuki, Someno, Tetsuya, Kawada, Manabu, Ikeda, Daishiro

    Published in Journal of antibiotics (01-07-2008)
    “…Angiogenesis is a critical step for the tumor therapy. Many angiogenic factors are involved in the tumor angiogenesis. In the course of our screening for…”
    Get full text
    Journal Article
  2. 2

    Phthoxazolin A inhibits prostate cancer growth by modulating tumor–stromal cell interactions by Kawada, Manabu, Inoue, Hiroyuki, Usami, Ihomi, Ikeda, Daishiro

    Published in Cancer science (01-01-2009)
    “…Because stroma in tumor tissues can promote prostate cancer development, modulation of tumor–stromal cell interactions may represent an attractive new strategy…”
    Get full text
    Journal Article
  3. 3

    Rakicidin A: A Hypoxia-Selective Cytotoxin by Yamazaki, Yohko, Kunimoto, Setsuko, Ikeda, Daishiro

    Published in Biological & Pharmaceutical Bulletin (01-02-2007)
    “…Hypoxia is a common feature of many solid tumors and contributes to their progression. Hypoxic cells in the tumor are not only involved in therapeutic…”
    Get full text
    Journal Article
  4. 4

    Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis by Wada, Shun‐ichi, Usami, Ihomi, Umezawa, Yoji, Inoue, Hiroyuki, Ohba, Shun‐ichi, Someno, Tetsuya, Kawada, Manabu, Ikeda, Daishiro

    Published in Cancer science (01-03-2010)
    “…(Cancer Sci 2010; 101: 743–750) Although cytostatin analog protein phosphatase 2A (PP2A)‐specific inhibitors are promising candidates of a new type of…”
    Get full text
    Journal Article
  5. 5

    Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer by KAWADA, Manabu, INOUE, Hiroyuki, MASUDA, Tohru, IKEDA, Daishiro

    Published in Cancer research (Chicago, Ill.) (15-04-2006)
    “…Prostate cancer shows high expression of type I insulin-like growth factor (IGF-I) receptor (IGF-IR) and prostate stromal cells (PrSC) produce IGF-I. Although…”
    Get full text
    Journal Article
  6. 6

    Leucinostatin A inhibits prostate cancer growth through reduction of insulin‐like growth factor‐I expression in prostate stromal cells by Kawada, Manabu, Inoue, Hiroyuki, Ohba, Shun‐Ichi, Masuda, Tohru, Momose, Isao, Ikeda, Daishiro

    Published in International journal of cancer (15-02-2010)
    “…Targeting stroma in tumor tissues is an attractive new strategy for cancer treatment. We developed in vitro coculture system, in which the growth of human…”
    Get full text
    Journal Article
  7. 7

    Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2 by Kawada, Manabu, Inoue, Hiroyuki, Ohba, Shun-ichi, Hatano, Masaki, Amemiya, Masahide, Hayashi, Chigusa, Usami, Ihomi, Abe, Hikaru, Watanabe, Takumi, Kinoshita, Naoko, Igarashi, Masayuki, Masuda, Tohru, Ikeda, Daishiro, Nomoto, Akio

    Published in Journal of antibiotics (01-09-2013)
    “…Because stromal cells can regulate the growth and metastasis of tumor cells, a compound that modulates the interaction between the stromal cells and the tumor…”
    Get full text
    Journal Article
  8. 8

    New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells by Kawada, Manabu, Momose, Isao, Someno, Tetsuya, Tsujiuchi, Goh, Ikeda, Daishiro

    Published in Journal of antibiotics (01-05-2009)
    “…The growth and metastasis of prostate cancer are regulated by prostate stroma through the tumor–stromal cell interactions. Small molecules that modulate the…”
    Get full text
    Journal Article
  9. 9

    In vivo imaging of proteasome inhibition using a proteasome‐sensitive fluorescent reporter by Momose, Isao, Tatsuda, Daisuke, Ohba, Shun‐ichi, Masuda, Tohru, Ikeda, Daishiro, Nomoto, Akio

    Published in Cancer science (01-09-2012)
    “…A proteasome degrades numerous regulatory proteins that are critical for tumor growth and is therefore recognized as a promising anticancer target. Determining…”
    Get full text
    Journal Article
  10. 10

    Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions by Momose, Isao, Ohba, Shun-ichi, Tatsuda, Daisuke, Kawada, Manabu, Masuda, Tohru, Tsujiuchi, Go, Yamori, Takao, Esumi, Hiroyasu, Ikeda, Daishiro

    “…Large areas of tumor are nutrient-starved and hypoxic due to a disorganized vascular system. Therefore, we screened small molecules to identify cytotoxic…”
    Get full text
    Journal Article
  11. 11

    Increased ABCB1 Expression in TP-110-Resistant RPMI-8226 Cells by IIJIMA, Masatomi, MOMOSE, Isao, IKEDA, Daishiro

    “…TP-110, a novel proteasome inhibitor, has been found to possess potent growth inhibition in human multiple myeloma cells. To enhance its therapeutic effects,…”
    Get full text
    Journal Article
  12. 12

    NBRI16716A, a new antitumor compound against human prostate cancer cells, produced by Perisporiopsis melioloides Mer-f16716 by Kawada, Manabu, Someno, Tetsuya, Inoue, Hiroyuki, Ohba, Shun-ichi, Masuda, Tohru, Kato, Taira, Ikeda, Daishiro

    Published in Journal of antibiotics (01-06-2010)
    “…Prostate stroma can regulate the growth and metastasis of prostate cancer through the tumor–stromal cell interactions. Thus, small molecules that modulate the…”
    Get full text
    Journal Article
  13. 13

    Structure–activity relationship of boronic acid derivatives of tyropeptin: Proteasome inhibitors by Watanabe, Takumi, Abe, Hikaru, Momose, Isao, Takahashi, Yoshikazu, Ikeda, Daishiro, Akamatsu, Yuzuru

    Published in Bioorganic & medicinal chemistry letters (01-10-2010)
    “…The structure–activity relationship of the boronic acid derivatives of tyropeptin, a proteasome inhibitor, was studied. Among 41 derivatives,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Synthesis of boronic acid derivatives of tyropeptin: Proteasome inhibitors by Watanabe, Takumi, Momose, Isao, Abe, Masatoshi, Abe, Hikaru, Sawa, Ryuichi, Umezawa, Yoji, Ikeda, Daishiro, Takahashi, Yoshikazu, Akamatsu, Yuzuru

    Published in Bioorganic & medicinal chemistry letters (15-04-2009)
    “…Synthesis of boronic acid derivatives ( 3a– c) of tyropeptin, proteasome inhibitors, are reported. Boronic acid derivatives of tyropeptin were synthesized with…”
    Get full text
    Journal Article
  16. 16

    Inhibitors of insulin-like growth factor-1 receptor tyrosine kinase are preferentially cytotoxic to nutrient-deprived pancreatic cancer cells by Momose, Isao, Kunimoto, Setsuko, Osono, Michiyo, Ikeda, Daishiro

    “…Chronic deprivation of nutrients is rare in normal tissues, however large areas of tumor are nutrient-starved and hypoxic due to a disorganized vascular…”
    Get full text
    Journal Article
  17. 17

    TP-110, a New Proteasome Inhibitor, Down-regulates IAPs in Human Multiple Myeloma Cells by IIJIMA, Masatomi, MOMOSE, Isao, IKEDA, Daishiro

    Published in Anticancer research (01-04-2009)
    “…TP-110, a new proteasome inhibitor, has previously shown potent growth inhibition in various tumor cell lines. In this study, the mechanism of TP-110-induced…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Ceramidastin, a novel bacterial ceramidase inhibitor, produced by Penicillium sp. Mer-f17067 by Inoue, Hiroyuki, Someno, Tetsuya, Kato, Taira, Kumagai, Hiroyuki, Kawada, Manabu, Ikeda, Daishiro

    Published in Journal of antibiotics (01-02-2009)
    “…Decrease of ceramide in the skin is one of the aggravating factors of atopic dermatitis. The skin is often infected by ceramidase-producing bacteria, such as…”
    Get full text
    Journal Article